EMCDDA Home
  • EN
Search

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (v) New inpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates5.540.629.013.76.22.51.21.222.33542299
Cocaine9.046.323.710.15.62.91.60.721.4553130
Stimulants14.259.517.24.92.30.90.70.519.1105163
Hypnotics and sedatives7.818.615.38.110.59.69.620.732.4334134
Hallucinogens4.545.518.222.74.54.50.00.022.12212
Volatile substances36.752.17.41.61.60.50.00.016.918815
Cannabis 38.844.710.53.51.50.50.40.117.31565192
Other substances 13.927.723.86.96.92.04.014.927.0101142
Total15.143.721.79.44.72.11.41.921.17356987

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY,HU, NL, AT, PL, RO, SK, FI, SE, UK, HR, TR 

 The number of treatment clients in each country is listed in Table TDI-7

 Last data available from Poland refer to 2008.                       

 See also Table TDI-108 on distribution by country and 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — Table TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 29 June 2011